{"id":93429,"date":"2026-03-11T12:14:55","date_gmt":"2026-03-11T09:14:55","guid":{"rendered":"https:\/\/www.egemtv.com\/?p=93429"},"modified":"2026-03-11T12:14:56","modified_gmt":"2026-03-11T09:14:56","slug":"ortopedide-eksozom-uygulamasi-umut-veriyor","status":"publish","type":"post","link":"https:\/\/www.egemtv.com\/?p=93429","title":{"rendered":"Ortopedide eksozom uygulamas\u0131 umut veriyor"},"content":{"rendered":"<p>Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. M. Naz\u0131m Karalezli, son y\u0131llarda g\u00fcndeme gelen eksozom tedavisi hakk\u0131nda bilgi verdi. Karalezli, y\u00f6ntemin h\u00fccrelerin iyile\u015ftirici sinyallerini kullanarak doku onar\u0131m\u0131n\u0131 destekledi\u011fini ancak hen\u00fcz bir\u00e7ok hastal\u0131k i\u00e7in standart tedavi haline gelmedi\u011fini s\u00f6yledi.<\/p>\n<p>Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. M. Naz\u0131m Karalezli, t\u0131pta son y\u0131llarda dikkat \u00e7eken eksozom tedavisi hakk\u0131nda a\u00e7\u0131klamalarda bulundu. Eksozomlar\u0131n, h\u00fccrelerin birbirleriyle ileti\u015fim kurmas\u0131n\u0131 sa\u011flayan \u00e7ok k\u00fc\u00e7\u00fck biyolojik paketler oldu\u011funu belirten Karalezli, bu yap\u0131lar\u0131n iyile\u015fme s\u00fcrecinde \u00f6nemli rol oynad\u0131\u011f\u0131n\u0131 ifade etti.<\/p>\n<p>Prof. Dr. Karalezli, eksozomlar\u0131n h\u00fccreler taraf\u0131ndan salg\u0131lanan ve iyile\u015fme sinyalleri ta\u015f\u0131yan yap\u0131lar oldu\u011funu belirterek, &#8220;Eksozomlar h\u00fccre yenilenmesini destekleyebilir ve iltihab\u0131 azaltmaya yard\u0131mc\u0131 olabilir. Bu tedavide do\u011frudan h\u00fccre de\u011fil, h\u00fccrelerin iyile\u015ftirici sinyalleri kullan\u0131l\u0131r&#8221; dedi.<\/p>\n<p>Ortopedide ve g\u00f6z hastal\u0131klar\u0131nda kullan\u0131l\u0131yor<br \/>\n<br \/>Eksozom tedavisinin \u00f6zellikle ortopedik rahats\u0131zl\u0131klarda kullan\u0131labildi\u011fini belirten Karalezli, &#8220;Diz kire\u00e7lenmesi (osteoartrit), omuz ve dizde g\u00f6r\u00fclen tendon problemleri ile kas ve ba\u011f yaralanmalar\u0131nda destekleyici tedavi olarak uygulanabiliyor&#8221; diye konu\u015ftu.<\/p>\n<p>Tedavinin baz\u0131 g\u00f6z hastal\u0131klar\u0131nda da ara\u015ft\u0131r\u0131ld\u0131\u011f\u0131n\u0131 ifade eden Karalezli, kuru g\u00f6z, kornea y\u00fczey hasar\u0131 ve baz\u0131 retina hastal\u0131klar\u0131nda bilimsel \u00e7al\u0131\u015fmalar\u0131n s\u00fcrd\u00fc\u011f\u00fcn\u00fc s\u00f6yledi.<\/p>\n<p>Uygulama k\u0131sa s\u00fcrede yap\u0131l\u0131yor<br \/>\n<br \/>Tedavinin uygulan\u0131\u015f\u0131na da de\u011finen Prof. Dr. Karalezli, ortopedik rahats\u0131zl\u0131klarda eksozomlar\u0131n genellikle eklem i\u00e7ine veya problemli tendon b\u00f6lgesine enjeksiyon \u015feklinde verildi\u011fini belirtti. G\u00f6z hastal\u0131klar\u0131nda ise damla \u015feklinde ya da baz\u0131 durumlarda g\u00f6z \u00e7evresine enjeksiyon \u015feklinde uygulanabildi\u011fini s\u00f6yledi.<\/p>\n<p>Karalezli, i\u015flemin genellikle k\u0131sa s\u00fcrd\u00fc\u011f\u00fcn\u00fc, \u00e7o\u011fu zaman lokal anestezi ile ger\u00e7ekle\u015ftirildi\u011fini ve hastanede yat\u0131\u015f gerektirmedi\u011fini vurgulad\u0131.<\/p>\n<p>Eksozomlar\u0131n v\u00fccutta \u00e7e\u015fitli etkiler olu\u015fturabilece\u011fini belirten Karalezli, &#8220;Eksozomlar iltihab\u0131 azaltmaya yard\u0131mc\u0131 olabilir, hasarl\u0131 dokunun onar\u0131m\u0131n\u0131 destekleyebilir ve h\u00fccre yenilenmesini te\u015fvik edebilir. Bu sayede a\u011fr\u0131n\u0131n azalmas\u0131na katk\u0131 sa\u011flayabilir&#8221; dedi.<\/p>\n<p>Ancak Karalezli, \u00f6zellikle ileri derecede kire\u00e7lenmelerde tamamen iyile\u015ftirici bir sonu\u00e7 beklenmemesi gerekti\u011fini ifade etti.<\/p>\n<p>Etkisi haftalar i\u00e7inde g\u00f6r\u00fclebiliyor<br \/>\n<br \/>Tedavinin etkisinin ki\u015fiden ki\u015fiye de\u011fi\u015febilece\u011fini belirten Karalezli, &#8220;Genellikle birka\u00e7 hafta i\u00e7inde etkiler ba\u015flar. Baz\u0131 hastalarda 2-3 ay i\u00e7inde belirgin rahatlama g\u00f6r\u00fclebilir. Etki s\u00fcresi ise hastan\u0131n durumuna g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir&#8221; dedi.<\/p>\n<p>Her hasta i\u00e7in uygun olmayabilir<br \/>\n<br \/>Eksozom tedavisinin genel olarak g\u00fcvenli kabul edildi\u011fini belirten Karalezli, enjeksiyon b\u00f6lgesinde ge\u00e7ici a\u011fr\u0131, \u015fi\u015flik ve hassasiyet gibi hafif yan etkiler g\u00f6r\u00fclebilece\u011fini s\u00f6yledi.<\/p>\n<p>Prof. Dr. Karalezli, s\u00f6zlerini \u015f\u00f6yle tamamlad\u0131:&#8221;Eksozom tedavisi rejeneratif t\u0131p alan\u0131nda umut verici bir y\u00f6ntemdir. Ancak hen\u00fcz bir\u00e7ok hastal\u0131k i\u00e7in standart tedavi de\u011fildir ve baz\u0131 uygulamalar h\u00e2l\u00e2 ara\u015ft\u0131rma a\u015famas\u0131ndad\u0131r. Bu nedenle tedavi \u00f6ncesinde mutlaka uzman de\u011ferlendirmesi yap\u0131lmas\u0131 gerekir.&#8221;<br \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. M. Naz\u0131m Karalezli, son y\u0131llarda g\u00fcndeme gelen eksozom tedavisi hakk\u0131nda bilgi verdi. Karalezli, y\u00f6ntemin h\u00fccrelerin iyile\u015ftirici sinyallerini kullanarak doku onar\u0131m\u0131n\u0131 destekledi\u011fini ancak hen\u00fcz bir\u00e7ok hastal\u0131k i\u00e7in standart tedavi haline gelmedi\u011fini s\u00f6yledi. Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. M. Naz\u0131m Karalezli, t\u0131pta son y\u0131llarda dikkat \u00e7eken eksozom tedavisi hakk\u0131nda a\u00e7\u0131klamalarda&#8230;<\/p>\n","protected":false},"author":1,"featured_media":93430,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-93429","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/93429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=93429"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/93429\/revisions"}],"predecessor-version":[{"id":93431,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/93429\/revisions\/93431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/93430"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=93429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=93429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=93429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}